Mike Nolan
Freenome has hired Mike Nolan as its chief commercial officer. In his new position, Nolan will be responsible for bringing Freenome's first AI-generated, genomic cancer screening test, a blood test for colorectal cancer, to market. Most recently, Nolan was senior vice president of commercial operations at Foundation Medicine. Overall, he has more than 25 years of experience in strategic management and commercial leadership at companies such as Thermo Fisher Scientific, Life Technologies, Luminex, and Roche Diagnostics.
Erica Ramos
Erica Ramos, president of the National Society of Genetic Counselors, will join Geisinger National Precision Health at the end of May as the director and head of clinical and business development. Ramos was previously at Illumina, where she was associate director of market development in clinical genomics and lead the company's precision health and screening programs.
Geisinger National aims to extend the genomics research and actionable health information generated within its MyCode Community Health Initiative. Ramos will be in charge of strategic partnerships focused on implementing the MyCode model in other communities around the country.
Cynthia Collins
DermTech, a developer of non-invasive molecular dermatology tests, has appointed Cynthia Collins to its board of directors. Collins most recently served as CEO of Human Longevity. She has also been CEO/GM of GE Healthcare's cell therapy business, lab businesses, and Clarient Diagnostics. Prior to GE, Collins was president and CEO of GenVec. Before that she was group vice president for the cellular analysis business at Beckman Coulter. She has also held executive positions with Sequoia Pharmaceuticals and Clinical Micro Sensors, a subsidiary of Motorola.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.